Skip to content
Explore in-depth articles and expert analysis on global aff…

Patients Coming Off Slimming Injections Gain Back Weight Far More Rapidly Than Dieters

Image of medical syringe and weighing machine
Obesity treatment often requires ongoing approaches.

Fresh analysis indicates that patients who discontinue popular slimming jabs like Wegovy and Mounjaro may regain lost weight far faster than those who stop conventional diet and exercise plans.

Findings released in a major health publication demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing such medications need to be cognizant of the potential of quick weight regain when the medication is stopped," stated expert Dr. Susan Jebb.

This pace of regain suggests a return to pre-treatment weight in about a year and a half.

Weighing Approaches

The analysis, which reviewed 37 of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills.

The team note that people who shed pounds through lifestyle changes alone usually have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Doctors propose the mechanism of the jabs explains the amplified weight return.

These medications mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Artificially providing the hormone levels far above than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Stopping of this medication results in hunger is uncontrolled, making overeating much more probable."

A Lifelong Condition?

Medical guidelines advise the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

A number of clinicians say that, given the likelihood of weight regain, the treatment might need to be life-long.

This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the chronic character of excess weight," similar to managing conditions like high blood pressure.

User Testimonies

Users who have stopped the medication report a sudden resurgence of appetite.

"It felt as if a trigger flipping and I was suddenly starving," said one woman.

The struggle is worsened if individuals have not adopted permanent lifestyle or habit modifications during treatment.

Significant Use

Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.

  • Adoption is more common among females than males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the medications through private healthcare rather than public health services.

In conclusion, experts stress that while the jabs are powerful tools for weight loss, they are not a magic solution and long-term success likely depends on ongoing behavioural changes.

About the author

Michael Ellison

A seasoned journalist and travel enthusiast with over a decade of experience covering international stories and cultural trends.

Royal Globe

Type to search articles.